S. Hescot

1.6k total citations
48 papers, 604 citations indexed

About

S. Hescot is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, S. Hescot has authored 48 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Surgery and 14 papers in Cancer Research. Recurrent topics in S. Hescot's work include Adrenal and Paraganglionic Tumors (15 papers), Thyroid Cancer Diagnosis and Treatment (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). S. Hescot is often cited by papers focused on Adrenal and Paraganglionic Tumors (15 papers), Thyroid Cancer Diagnosis and Treatment (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). S. Hescot collaborates with scholars based in France, United States and Italy. S. Hescot's co-authors include Éric Baudin, Sophie Leboulleux, Marc Lombès, Julien Hadoux, Angélo Paci, Jacques Young, Séverine Trabado, Martin Schlumberger, Delphine Loirat and A. Berdelou and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and British Journal of Cancer.

In The Last Decade

S. Hescot

43 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Hescot France 15 285 233 222 191 107 48 604
Tricia A. Moo‐Young United States 15 277 1.0× 326 1.4× 66 0.3× 227 1.2× 49 0.5× 34 687
Matti L. Gild Australia 16 142 0.5× 511 2.2× 101 0.5× 254 1.3× 97 0.9× 53 824
Angelo Giovanni Bonadio Italy 10 101 0.4× 109 0.5× 99 0.4× 120 0.6× 52 0.5× 24 398
Sylwia Szpak‐Ulczok Poland 14 112 0.4× 358 1.5× 130 0.6× 112 0.6× 74 0.7× 28 645
Kenichi Matsuzu Japan 18 428 1.5× 815 3.5× 104 0.5× 173 0.9× 94 0.9× 57 1.0k
Quan-Yang Duh United States 9 137 0.5× 335 1.4× 76 0.3× 124 0.6× 41 0.4× 9 517
Jingqiang Zhu China 17 316 1.1× 507 2.2× 142 0.6× 143 0.7× 55 0.5× 47 740
Sheila Lindsay United States 12 117 0.4× 296 1.3× 53 0.2× 189 1.0× 36 0.3× 19 569
Helina Somervell United States 14 308 1.1× 360 1.5× 36 0.2× 111 0.6× 82 0.8× 20 718
David Saavedra-Pérez Spain 9 149 0.5× 44 0.2× 142 0.6× 276 1.4× 163 1.5× 29 580

Countries citing papers authored by S. Hescot

Since Specialization
Citations

This map shows the geographic impact of S. Hescot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hescot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hescot more than expected).

Fields of papers citing papers by S. Hescot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hescot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hescot. The network helps show where S. Hescot may publish in the future.

Co-authorship network of co-authors of S. Hescot

This figure shows the co-authorship network connecting the top 25 collaborators of S. Hescot. A scholar is included among the top collaborators of S. Hescot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hescot. S. Hescot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacour, Brigitte, S. Hescot, M. Le Bras, et al.. (2025). Bronchial Carcinoid Tumors in Children and Adolescents. Pediatric Blood & Cancer. 72(8). e31822–e31822. 3 indexed citations
2.
Cao, Christine Do, Yann Godbert, Stéphane Bardet, et al.. (2025). ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer. Annales d Endocrinologie. 86(4). 101735–101735.
3.
Lasolle, Hélène, Christine Do Cao, Livia Lamartina, et al.. (2025). ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer. Annales d Endocrinologie. 86(4). 101733–101733.
4.
Orbach, Daniel, S. Hescot, Emmanuel Désandes, et al.. (2024). Childhood pancreatic neuroendocrine neoplasms: A national experience. Pediatric Blood & Cancer. 72(2). e31258–e31258. 5 indexed citations
5.
Bellera, Carine, Jean‐Philippe Guégan, Julien Hadoux, et al.. (2024). 1925MO Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC). Annals of Oncology. 35. S1120–S1120. 1 indexed citations
6.
Hescot, S., Laurent M. Sachs, Peter Kamenický, et al.. (2023). SAT278 Thyroid Hormones Regulate 11bhsd Enzymes: A Novel Function In Glucocorticoid Hormone Metabolism. Journal of the Endocrine Society. 7(Supplement_1).
7.
Faron, Matthieu, Livia Lamartina, S. Hescot, et al.. (2022). New endpoints in adrenocortical carcinoma studies: a mini review. Endocrine. 77(3). 419–424. 1 indexed citations
8.
Hescot, S., Abir Al Ghuzlan, Livia Lamartina, et al.. (2022). Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocrine Related Cancer. 29(11). 625–634. 14 indexed citations
9.
Doubre, H., Élisabeth Longchampt, Diane Damotte, et al.. (2021). ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors. Clinical Lung Cancer. 22(5). e686–e690. 5 indexed citations
10.
11.
Lamartina, Livia, Yann Godbert, Christine Do Cao, et al.. (2020). Locally unresectable differentiated thyroid cancer: outcomes and perspectives. Endocrine. 69(1). 133–141. 12 indexed citations
12.
Cros, Jérôme, Nathalie Théou–Anton, V. Gounant, et al.. (2020). Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology. Neuroendocrinology. 111(1-2). 158–169. 32 indexed citations
13.
Tourneau, Christophe Le, Jean‐Pierre Delord, Nuria Kotecki, et al.. (2020). A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours. British Journal of Cancer. 123(10). 1481–1489. 5 indexed citations
14.
15.
Gravel, Guillaume, Sophie Leboulleux, Lambros Tselikas, et al.. (2018). Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma. Endocrine. 59(3). 547–554. 22 indexed citations
16.
Haı̈ssaguerre, Michel, S. Hescot, Jérôme Bertherat, & Olivier Chabre. (2018). Expert opinions on adrenal complications in immunotherapy. Annales d Endocrinologie. 79(5). 539–544. 12 indexed citations
17.
Hescot, S., Atmane Seck, Maryse Guérin, et al.. (2015). Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 100(8). 2890–2898. 27 indexed citations
18.
Hescot, S., Angélo Paci, Atmane Seck, et al.. (2014). The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment. Hormones and Cancer. 5(5). 312–323. 21 indexed citations
19.
Hescot, S., Abdelhamid Slama, Anne Lombès, et al.. (2013). Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocrine Related Cancer. 20(3). 371–381. 76 indexed citations
20.
Hescot, S., Éric Baudin, Françoise Borson‐Chazot, & Marc Lombès. (2013). Thérapies ciblées en oncologie endocrinienne : facteurs pronostiques et prédictifs de réponse. Annales d Endocrinologie. 74. S13–S22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tricia A. Moo‐Young Breakdown of academic impact, for papers by Matti L. Gild Breakdown of academic impact, for papers by Angelo Giovanni Bonadio Breakdown of academic impact, for papers by Sylwia Szpak‐Ulczok Breakdown of academic impact, for papers by Kenichi Matsuzu Breakdown of academic impact, for papers by Quan-Yang Duh Breakdown of academic impact, for papers by Jingqiang Zhu Breakdown of academic impact, for papers by Sheila Lindsay Breakdown of academic impact, for papers by Helina Somervell Breakdown of academic impact, for papers by David Saavedra-Pérez
Rankless by CCL
2026